DRUG TARGETS FOR ALZHEIMER'S DISEASE AND OTHER DISEASES ASSOCIATED WITH DECREASED NEURONAL METABOLISM

Details for Australian Patent Application No. 2002336759 (hide)

Owner ACCERA, INC.

Inventors HENDERSON, Samuel, T.

Pub. Number AU-A-2002336759

PCT Number PCT/US02/30145

PCT Pub. Number WO2003/028631

Priority 60/323,995 21.09.01 US

Filing date 23 September 2002

Wipo publication date 14 April 2003

Event Publications

20 February 2003 Complete Application Filed

  Priority application(s): 60/323,995 21.09.01 US

26 June 2003 Application Open to Public Inspection

  Published as AU-A-2002336759

17 June 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002336760-MUTABLE VACCINES

2002336758-INTEGRATED LANCING AND ANALYTIC DEVICE